Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 24Active not recruiting 9Not yet recruiting 3Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 58Neoplasms 51Colorectal Neoplasms 32Prostatic Neoplasms 29Carcinoma, Non-Small-Cell Lung 25Lung Neoplasms 23Leukemia, Myeloid, Acute 20Recurrence 12Multiple Myeloma 12Head and Neck Neoplasms 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Neoplasm Metastasis 11Melanoma 11Squamous Cell Carcinoma of Head and Neck 10Lymphoma, Non-Hodgkin 10Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Brain Neoplasms 9Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Myelodysplastic Syndromes 8Motor Activity 8Lymphoma 8Glioma 8Esophageal Neoplasms 8Carcinoma, Renal Cell 8Leukemia 7Glioblastoma 7Polycystic Ovary Syndrome 6

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × 30 days × Clear all
NCT00086567 2026-06-05

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

National Institutes of Health Clinical Center (CC)

Completed
119 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT03430700 2026-05-20

PROMPT

University College, London

Phase 2 Completed
20 enrolled 10 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡